AMRA Medical

AMRA Medical is a global leader in MRI-based body composition analysis, transforming standard MRI scans into precise, quantitative biomarkers for fat and muscle. Its platform serves two primary markets: supporting pharmaceutical R&D in metabolic and musculoskeletal diseases through its Research Services, and enabling personalized clinical assessments via its CE-marked medical device, AMRA® Profiler. With a robust scientific foundation evidenced by over 200 publications and a large reference dataset, the company is positioned at the intersection of advanced imaging, biomarkers, and digital health.

Proprietary software that analyzes standard whole-body MRI scans to perform automated, volumetric quantification of body composition (fat distribution and muscle composition), delivering precise biomarkers.

AMRA competes with traditional body composition methods (DXA, BIA, CT anthropometry) and a growing field of AI-based medical imaging analytics companies. Its primary differentiation is the precision and comprehensiveness of its whole-body MRI analysis, its large normative database, and its focus specifically on fat and muscle biomarkers, backed by extensive peer-reviewed research.